Wealth Enhancement Trust Services’s CONMED CNMD Stock Holding History

Wealth Enhancement Trust Services’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.28K	Buy	+39	New	+$1.4K	﹤0.01%	1068

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Wealth Enhancement Trust Services's CNMD Position: Q2 2026 in Review

Wealth Enhancement Trust Services opened a new position in CONMED (CNMD) in Q2 2026: 39 shares worth $1.28K. The stake represents ﹤0.01% of the portfolio and ranks #1068 among its holdings.

158 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

Wealth Enhancement Trust Services held 39 shares of CONMED worth $1.28K as of Q2 2026.
CONMED was a new Wealth Enhancement Trust Services position in Q2 2026.
CONMED made up ﹤0.01% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #1068 holding.
158 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.